Skip to main content
Home
Toggle menu

  • Home

Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine




Mon, 10/07/2024 - 14:15

Gizmodo

Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, arrives at federal court in the Brooklyn borough of New York, U.S., on Thursday, Aug. 3, 2017.

There were no generic alternatives to a lifesaving drug when Shkreli jacked up its price by more than $700 per pill in 2015.

Tags
Crime, News, daraprim, martin shkreli, Supreme Court

Source
Supreme Court Snubs Martin Shkreli’s Last-Ditch Bid to Avoid $64 Million Fine
sfy39587stp18